Testing effectiveness (Phase 2)Looking for participantsNCT04977180What this trial is testingCardioprotection in AMLWho this might be right forAMLAcute Myeloid Leukemia University of Virginia 70
Early research (Phase 1)Study completedNCT03514069What this trial is testingRuxolitinib With Radiation and Temozolomide for Grade III Gliomas and GlioblastomaWho this might be right forGliomaGlioblastoma Case Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)Ended earlyNCT00038142What this trial is testingVincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma PatientsWho this might be right forEwing's Sarcoma M.D. Anderson Cancer Center 46
Early research (Phase 1)Study completedNCT00390403What this trial is testingGossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Large-scale testing (Phase 3)Not Yet RecruitingNCT07712588What this trial is testingBirelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)Who this might be right forDiffuse Large B-Cell Lymphoma (DLBCL) Dizal Pharmaceuticals 880
Testing effectiveness (Phase 2)Study completedNCT02586038What this trial is testingSTUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTSWho this might be right forMultiple Myeloma Mario Boccadoro 175
Testing effectiveness (Phase 2)Looking for participantsNCT06533748What this trial is testingTherapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and LymphomaWho this might be right forAcute Lymphoblastic LeukemiaLymphoblastic Lymphoma St. Jude Children's Research Hospital 128
Testing effectiveness (Phase 2)WithdrawnNCT01670084What this trial is testingNilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous LeukemiaWho this might be right forB-cell Adult Acute Lymphoblastic LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+2 more Mayo Clinic
Testing effectiveness (Phase 2)UnknownNCT05503355What this trial is testingA Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AMLWho this might be right forAML, Adult BioSight Ltd. 80
Not applicableUnknownNCT04856852What this trial is testingIodine-125 Brachytherapy Together With Chemotherapy in Patients With Newly Diagnosed GlioblastomaWho this might be right forGlioblastoma The Affiliated Hospital of Qingdao University 84
Large-scale testing (Phase 3)Study completedNCT00103285What this trial is testingCombination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaChildhood B Acute Lymphoblastic Leukemia Children's Oncology Group 5,377
Not applicableLooking for participantsNCT06222138What this trial is testingStudy of Biologic Tumor and Plasma Biomarkers of Response to TTFields in Patients Treated for Newly Diagnosed GlioblastomaWho this might be right forGlioblastoma Institut Claudius Regaud 80
Not applicableStudy completedNCT00594815What this trial is testingCombined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT00662506What this trial is testingCediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed GlioblastomaWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma National Cancer Institute (NCI) 46
Very early researchStudy completedNCT01957956What this trial is testingVaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed GlioblastomaWho this might be right forGiant Cell GlioblastomaGlioblastomaGliosarcoma Mayo Clinic 21
Testing effectiveness (Phase 2)UnknownNCT02533700What this trial is testingCEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCLWho this might be right forPeripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T Cell LymphomaALK-negative Anaplastic Large Cell Lymphoma+3 more Shandong Provincial Hospital 106
Testing effectiveness (Phase 2)Study completedNCT01702831What this trial is testingBusulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide MaintenanceWho this might be right forMultiple Myeloma University Health Network, Toronto 78
Testing effectiveness (Phase 2)Study completedNCT00902577What this trial is testingMRI and PET/FMISO In Assessing Tumor Hypoxia in Patients With Newly Diagnosed Glioblastoma MultiformeWho this might be right forAdult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Study completedNCT00727831What this trial is testingMethotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System LymphomaWho this might be right forChemotherapeutic Agent ToxicityLymphomaMucositis+1 more University College, London 4
Testing effectiveness (Phase 2)Study completedNCT00100802What this trial is testingRadiation Therapy, Temozolomide, and Lomustine in Treating Young Patients With Newly Diagnosed GliomasWho this might be right forAnaplastic AstrocytomaCentral Nervous System NeoplasmGlioblastoma+2 more Children's Oncology Group 118